指南与共识乳腺癌放疗放疗物理与技术

乳腺癌放疗后心脏死亡与QUANTEC心脏指南

Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines.
指南 / 共识 · Clin Transl Radiat Oncol · 2019-08-13

该研究基于人群数据库,分析2002至2006年接受乳腺/胸壁放疗的早期乳腺癌患者,评估心血管死亡者是否违反QUANTEC心脏指南。结果显示左乳放疗后心血管死亡者均未违反V25Gy<10%的QUANTEC约束,且当MHD<3.3 Gy和LAD最大剂量<45.4 Gy时10年心脏死亡风险很低。

要点

  • 左乳放疗后心血管死亡患者心脏V25Gy均未超过10%,未违反QUANTEC指南。
  • 10年心血管死亡率左乳1.7%、右乳1.3%,整体1.4%。
  • MHD<3.3 Gy且LAD最大EQD2<45.4 Gy时,10年放疗诱导心脏死亡风险很低。

核心结论

  • 左乳放疗后死于心血管疾病的患者均未违反QUANTEC心脏指南。
  • 当MHD<3.3 Gy且LAD最大剂量(EQD2 3 Gy)<45.4 Gy时,10年放疗诱导心脏死亡风险似乎很低。

研究设计与样本

  • 基于人群数据库识别2002至2006年接受辅助乳腺/胸壁放疗的早期乳腺癌女性,分析其中心血管死亡病例。
  • 心血管死亡患者按2:1匹配未死于心血管疾病的对照,左侧病例回顾性勾画心脏和LAD并计算剂量体积直方图。

主要发现

  • 5249例 eligible 患者中,76例(10年1.4%)于2015年6月前死于心血管疾病。
  • 任何左侧病例的心脏V25Gy均未超过10%,且无心脏剂量学参数能区分左侧病例与对照。

关键数值与推荐

  • QUANTEC指南规定部分心脏照射时V25Gy<10%与心脏死亡概率<1%相关。
  • 本研究中左侧病例心脏V25Gy均未超过10%。

临床怎么用

  • 对于左侧乳腺癌放疗,心脏V25Gy<10%的QUANTEC约束在心血管死亡患者中均未违反,支持该约束的临床适用性。
  • MHD<3.3 Gy和LAD最大EQD2<45.4 Gy可能与10年心脏死亡风险很低相关,但需进一步研究验证。

局限性

  • 需进一步研究在CT计划时代评估心脏和LAD约束。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast/chest wall irradiation (RT) increases risk of cardiovascular death. International Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) guidelines state for partial heart irradiation a "V25Gy <10% will be associated with a <1% probability of cardiac mortality" in long-term follow-up after RT. We assessed whether women treated with breast/chest wall RT 10-years ago who died of cardiovascular disease (CVD) violated QUANTEC guidelines. MATERIALS/METHODS: A population-based database identified all cardiovascular deaths in women with early-stage breast cancer <80 years, treated with adjuvant breast/chest wall RT from 2002 to 2006. Ten-year rate of cardiovascular death was calculated using a Kaplan-Meier method. Patients were matched on a 2:1 basis with controls that did not die of CVD. For left-sided cases, the heart and left anterior descending (LAD) artery were retrospectively delineated. Dose-volume histograms were calculated, and heart V25Gy compared to QUANTEC guidelines. RESULTS: 5249 eligible patients received breast/chest wall RT from 2002 to 2006: 76 (1.4% at 10-years) died of CVD by June 2015. Forty-two patients received left-sided RT (1.7% CVD death at 10-years), 34 right-sided RT (1.3% at 10-years). Heart V25Gy did not exceed 10% in any left-sided cases. No cardiac dosimetry parameter distinguished left-sided cases from controls. CONCLUSIONS: QUANTEC guidelines were not violated in any patient that died of CVD after left-sided RT. The risk of radiation induced cardiac death at 10-years appears to be very low if MHD is <3.3 Gy and maximum LAD dose (EQD23 Gy) is <45.4 Gy. Further studies are needed to evaluate heart and LAD constraints in the CT-planning era.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Beaton L, Bergman A, Nichol A, et al. Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines. Clin Transl Radiat Oncol. 2019. PMID: 31485490. doi:10.1016/j.ctro.2019.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。